Warren RB, Reich A, Kaszuba A, Placek W, et al. Imsidolimab, an Anti-IL-36 Receptor Monoclonal Antibody for the Treatment of Generalised Pustular Psoriasis: Results from the Phase 2 GALLOP Trial. Br J Dermatol 2023 Apr 30:ljad083. doi: 10.1093.
PMID: 37120722